Doraiswamy Vinayak, Chief Scientific Officer at AtriCure, Inc. ($ATRC), sold shares on the open market twice in the last 365 days for a total of $175 thousand. His most recent sale occurred on August 5, 2025. These sales rank him 8,715th among over 11,678 insiders by total amount sold, well below the average of nearly $8.6 million across about 6 transactions per insider. Vinayak made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | S | Common Stock | 5000 | $29.83 | 96,875.0000 | 49,809,901 | 4.91% | 0.01% |
| March 1, 2026 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | F | Common Stock | 15585 | $31.26 | 101,875.0000 | 49,809,901 | 13.27% | 0.03% |
| March 1, 2026 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 30390 | $0.00 | 102,262.0000 | 49,809,901 | 42.28% | 0.06% |
| March 1, 2026 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 15198 | $0.00 | 117,460.0000 | 49,809,901 | 14.86% | 0.03% |
| Aug. 5, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | S | Common Stock | 2500 | $36.58 | 71,872.0000 | 48,879,604 | 3.36% | 0.01% |
| June 30, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 822 | $25.84 | 74,372.0000 | 48,879,604 | 1.12% | 0.00% |
| May 28, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | S | Common Stock | 2500 | $33.44 | 73,550.0000 | 48,879,604 | 3.29% | 0.01% |
| March 1, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 19359 | $0.00 | 79,143.0000 | 48,879,604 | 32.38% | 0.04% |
| March 1, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 6579 | $0.00 | 85,722.0000 | 48,879,604 | 8.31% | 0.01% |
| March 1, 2025 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | F | Common Stock | 9672 | $38.74 | 76,050.0000 | 48,879,604 | 11.28% | 0.02% |
| June 28, 2024 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 707 | $19.35 | 59,784.0000 | 0 | 1.20% | 0.00% |
| March 1, 2024 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | F | Common Stock | 8855 | $36.28 | 59,077.0000 | 0 | 13.04% | 0.00% |
| March 1, 2024 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 9328 | $0.00 | 67,932.0000 | 0 | 15.92% | 0.00% |
| March 1, 2024 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 19294 | $0.00 | 58,604.0000 | 0 | 49.08% | 0.00% |
| June 30, 2023 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 557 | $38.11 | 39,310.0000 | 0 | 1.44% | 0.00% |
| March 1, 2023 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | F | Common Stock | 4793 | $38.81 | 38,753.0000 | 0 | 11.01% | 0.00% |
| March 1, 2023 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 8036 | $0.00 | 27,442.0000 | 0 | 41.41% | 0.00% |
| March 1, 2023 | AtriCure, Inc. | $ATRC | Doraiswamy Vinayak | Chief Scientific Officer | A | Common Stock | 16104 | $0.00 | 43,546.0000 | 0 | 58.68% | 0.00% |